TITLE

Bayer to sell diagnostics business to Siemens for EUR 4.2 billion

PUB. DATE
July 2006
SOURCE
Chemical Business;Jul2006, Vol. 20 Issue 7, p91
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the plan of Bayer Group to sell the diagnostics division of Bayer HealthCare to Siemens AG for 4.2 billion Euro. It is said that Bayer is selling the division as part of the consolidation phase in the diagnostics market. There was an 8.4 percent increase in sales of Bayer HealthCare Diagnostics in 2005.
ACCESSION #
22604776

 

Related Articles

  • Managers Get Bayer's Allergy Unit. Schmitt, Bill // Chemical Week;3/17/1999, Vol. 161 Issue 10, p23 

    Details the plan of Bayer AG to sold its allergy products unit to a group of unit's senior managers who will operate it as an independent pharmaceutical manufacturing company. Plans of the managers for the business; Products developed by the company.

  • Siemens aims to sell MPM as a block. Bregar, Bill // Plastics News;11/27/2000, Vol. 12 Issue 39, p1 

    Announces the sale of Mannesmann Plastics Machinery AG by Siemens AG in Munich, Germany. Impact on the plastics industry; List of potential buyers; Possibilities of selling through initial public offering.

  • Bayer Says BMS Is Core for Now, Eyes Higher Pharma Rank. ALPEROWICZ, NATASHA // Chemical Week;3/7/2011, Vol. 173 Issue 6, p21 

    The article reports on the business performance of chemical manufacturer Bayer. According to chairman Marijin Dekkers, the company is committed to its current portfolios, which include Bayer Healthcare, Bayer CropScience, and Bayer MaterialScience (BMS), because of their very good market...

  • Bayer pulls fibre deal...  // Urethanes Technology;Jun/Jul2002, Vol. 19 Issue 3, p6 

    Reports on the withdrawal of the plan of Bayer AG to sell Bayer Faser GmBH as of June 2002. Reason for the move; Effort of the company to boost the value of the unit; Investment of Bayer to expand the capacity of its polyurethane dispersions facility at Dormagen, Germany.

  • Bayer TiO2 sale imminent.  // Chemical Week;12/24/1997, Vol. 159 Issue 48, p4 

    Announces the sale or merger of the titanium dioxide business of Bayer AG at Leverkusen, Germany by the end of 1997. Potential buyer of the business.

  • Bayer to spin off MaterialScience.  // TCE: The Chemical Engineer;Nov2014, Issue 881, p7 

    The article reports on the plan of chemical and pharmaceutical company Bayer to spin off its MaterialScience division as a separate company to focus on its life sciences businesses namely HealthCare and CropScience.

  • Bayer Intends to Divest Blood Plasma Business.  // Chemical Market Reporter;10/6/2003, Vol. 264 Issue 11, p3 

    Reports on the plans of Bayer AG to divest the blood plasma business in North Carolina. Retention of the Kogenate product line; List of products included in the sales of the blood plasma business.

  • CERNER. Investor's Business Daily // Investors Business Daily;8/ 6/2014, pA02 

    The article reports on the acquisition of health information technology (IT) business unit of electronic and industrial engineering company Siemens AG by medical software maker Cerner.

  • Siemens gets approval for Atecs buyout. Chew, Edmund // Automotive News Europe;09/11/2000, Vol. 5 Issue 19, p13 

    Reports that the European Commission has approved the sale of three Atecs Mannesmann units to Siemens AG, but has delayed its decision on whether Robert Bosch GmbH can buy Rexroth AG, a fourth Atecs unit. Appointment of Franz Wressnigg; Conclusions made by the commission; Acquisition of Dematic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics